These results expect experts for the upcoming Pfizer balance.
Pfizer invites you to the regular financial conference on 05.08.2025 and will publish the figures there for the recent quarter, which ended on June 30, 2025.
According to 14 analysts for the past quarter, the profit per share should amount to an average of $ 0.581 per share. In the previous year’s quarter, Pfizer had generated USD 0.010 per share.
In the past quarter, Pfizer is said to have implemented $ 13.56 billion according to the forecasts of 13 analysts. This corresponds to an increase of 2.09 percent compared to the previous year’s value. At that time, $ 13.28 billion had been implemented.
With a view to the current fiscal year, 20 analysts assume on average from a profit per share of $ 3.02, while 1.41 USD had been reported in the same period last year. In sales, 19 analysts assume that a total of $ 62.58 billion will be in the books in the current fiscal year, compared to $ 63.63 billion in the previous year.
Editor finance.net
By the way: Pfizer and other US shares are even tradable at Finance.net Zero until 11 p.m. (without order fees, plus spreads). Open Depot now for free And receive a free stock as a gift.
Selected leverage products on Pfizer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we show you suitable open-end products on Pfizer
The lever must be between 2 and 20
Advertising